PDF(Pubmed)
Abstract：
UNASSIGNED: An increasing number of Canadians are registering as authorized users of medical cannabis. Older patients comprise a growing subset of this population; however, relatively little information exists around age-related patterns of medical cannabis use.
UNASSIGNED: The Canadian Cannabis Patient Survey (CCPS) is a large cross-sectional survey of authorized medical cannabis patients in Canada. This publication summarizes the results of the CCPS 2021, with a focus on age-related outcomes and the elderly sub-population.
UNASSIGNED: The survey was completed by 2,697 patients. The mean age of participants was 54.3 years of age and the proportion of female respondents was 49.1%. Among older patients, pain was the most common symptom, while anxiety was the most common symptom reported by younger patients. Older patients exhibited a significant preference for oral administration over inhalation of medical cannabis when compared to younger patients, respectively (p>0.05). Among patients taking prescription opioids, most of whom were older patients, 54% reported a decrease in use concurrent with medical cannabis.
UNASSIGNED: Older patients comprise a growing subset of medical cannabis patients, which is also reflected in CCPS participants over time. This patient population exhibits different patterns of use compared to their younger counterparts, preferring high CBD orally ingested formulations, which they use primarily to treat pain-related illnesses/symptoms. Overall, study participants reported that cannabis had a high degree of efficacy in alleviating their illness/symptoms, and many reported a reduction in their use of prescription opioids, alcohol, tobacco, and other substances.
UNASSIGNED: The Canadian Cannabis Patient Survey (CCPS) is a large cross-sectional survey of authorized medical cannabis patients in Canada. This publication summarizes the results of the CCPS 2021, with a focus on age-related outcomes and the elderly sub-population.
UNASSIGNED: The survey was completed by 2,697 patients. The mean age of participants was 54.3 years of age and the proportion of female respondents was 49.1%. Among older patients, pain was the most common symptom, while anxiety was the most common symptom reported by younger patients. Older patients exhibited a significant preference for oral administration over inhalation of medical cannabis when compared to younger patients, respectively (p>0.05). Among patients taking prescription opioids, most of whom were older patients, 54% reported a decrease in use concurrent with medical cannabis.
UNASSIGNED: Older patients comprise a growing subset of medical cannabis patients, which is also reflected in CCPS participants over time. This patient population exhibits different patterns of use compared to their younger counterparts, preferring high CBD orally ingested formulations, which they use primarily to treat pain-related illnesses/symptoms. Overall, study participants reported that cannabis had a high degree of efficacy in alleviating their illness/symptoms, and many reported a reduction in their use of prescription opioids, alcohol, tobacco, and other substances.
摘要：
■越来越多的加拿大人注册为医用大麻的授权使用者。老年患者占这一人群的比例越来越高；然而，关于与年龄相关的医用大麻使用模式的信息相对较少。
■加拿大大麻患者调查（CCPS）是对加拿大授权医疗大麻患者的大型横断面调查。本出版物总结了2021年CCPS的结果，重点是与年龄相关的结果和老年人群。
■该调查由2,697名患者完成。参与者的平均年龄为54.3岁，女性受访者的比例为49.1%。在老年患者中，疼痛是最常见的症状,而焦虑是年轻患者报告的最常见症状。与年轻患者相比，老年患者对口服给药明显优于吸入医用大麻，分别为(p>0.05)。在服用处方阿片类药物的患者中，其中大多数是老年患者，54%的人报告说，与医用大麻同时使用的情况有所减少。
■老年患者包括越来越多的医用大麻患者，随着时间的推移，这也反映在CCPS参与者中。与年轻的患者相比，该患者群体表现出不同的使用模式，更喜欢口服高CBD的配方，它们主要用于治疗疼痛相关的疾病/症状。总的来说,研究参与者报告说，大麻在缓解他们的疾病/症状方面具有高度的功效，许多人报告说他们减少了处方阿片类药物的使用，酒精,烟草,和其他物质。
■加拿大大麻患者调查（CCPS）是对加拿大授权医疗大麻患者的大型横断面调查。本出版物总结了2021年CCPS的结果，重点是与年龄相关的结果和老年人群。
■该调查由2,697名患者完成。参与者的平均年龄为54.3岁，女性受访者的比例为49.1%。在老年患者中，疼痛是最常见的症状,而焦虑是年轻患者报告的最常见症状。与年轻患者相比，老年患者对口服给药明显优于吸入医用大麻，分别为(p>0.05)。在服用处方阿片类药物的患者中，其中大多数是老年患者，54%的人报告说，与医用大麻同时使用的情况有所减少。
■老年患者包括越来越多的医用大麻患者，随着时间的推移，这也反映在CCPS参与者中。与年轻的患者相比，该患者群体表现出不同的使用模式，更喜欢口服高CBD的配方，它们主要用于治疗疼痛相关的疾病/症状。总的来说,研究参与者报告说，大麻在缓解他们的疾病/症状方面具有高度的功效，许多人报告说他们减少了处方阿片类药物的使用，酒精,烟草,和其他物质。
